| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), GRDX's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.08M | - | - | |
| Dir | 177.3K | $984.2K | - | |
| CFO | 140.0K | - | - | |
| Dir | 140.0K | - | - | |
| Dir | 80.0K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 28, 2018 | Casamento Charles J71 | Director | Buy | 9,000 | $1.41 | $12,690.00 | +18.9% | |
| Dec 28, 2018 | Shenouda Maged52 | Chief Financial Officer | Buy | 20,000 | $1.31 | $26,214.00 | +47.1% | |
| Jun 30, 2017 | Pelican Partners LLC | 10% Owner | Sell | 160,000 | $3.19 | $510,000.00 | -8.5% | |
| Jun 5, 2017 | Ross Edmund Burke Jr. | 10% Owner | Buy | 128,572 | $3.50 | $450,002.00 | +8.4% |